Cargando…
Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling
The development of cancer therapies may be improved by the discovery of tumor-specific molecular dependencies. The requisite tools include genetic and chemical perturbations, each with its strengths and limitations. Chemical perturbations can be readily applied to primary cancer samples at large sca...
Autores principales: | Batzilla, Alina, Lu, Junyan, Kivioja, Jarno, Putzker, Kerstin, Lewis, Joe, Zenz, Thorsten, Huber, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436053/ https://www.ncbi.nlm.nih.gov/pubmed/35994503 http://dx.doi.org/10.1371/journal.pcbi.1010438 |
Ejemplares similares
-
Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies
por: Lukas, Marina, et al.
Publicado: (2020) -
Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity
por: Lu, Junyan, et al.
Publicado: (2019) -
Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay
por: Rebelo, Maria, et al.
Publicado: (2015) -
Modifying and Integrating in vitro and ex vivo Respiratory Models for Inhalation Drug Screening
por: Cidem, Aylin, et al.
Publicado: (2020) -
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay
por: Stieglitz, Elliot, et al.
Publicado: (2023)